Company Filing History:
Years Active: 2017
Title: Yibin Yang: Innovator in Ubiquitin Research
Introduction
Yibin Yang is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of peptide inhibitors targeting the linear ubiquitin chain assembly complex (LUBAC). His work has implications for treating various diseases, including activated B-cell like diffuse large B cell lymphoma (ABC DLBCL) and autoimmune or inflammatory disorders.
Latest Patents
Yibin Yang holds a patent for "Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods." This invention focuses on peptide inhibitors that can potentially revolutionize treatment options for specific types of cancers and inflammatory conditions. He has 1 patent to his name, showcasing his innovative approach to addressing complex medical challenges.
Career Highlights
Yang is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His role at this esteemed institution allows him to engage in cutting-edge research and collaborate with other leading scientists in the field. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Throughout his career, Yibin Yang has collaborated with notable colleagues, including Louis M. Staudt and Federico Bernal. These partnerships have fostered a rich environment for innovation and discovery, contributing to the advancement of knowledge in the field of cancer research and treatment.
Conclusion
Yibin Yang's contributions to the field of biomedical research, particularly through his patent on LUBAC inhibitors, highlight his role as an innovator dedicated to improving healthcare solutions. His work continues to inspire advancements in the treatment of complex diseases.